# Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

> **NCT05229341** · NA · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 1450 (estimated)

## Conditions studied

- Thyroid Gland Carcinoma

## Interventions

- **PROCEDURE:** Diagnostic Procedure
- **OTHER:** Electronic Health Record Review
- **PROCEDURE:** Needle Biopsy

## Key facts

- **NCT ID:** NCT05229341
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-22
- **Primary completion:** 2026-10-22
- **Final completion:** 2026-10-22
- **Target enrollment:** 1450 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05229341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05229341, "Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05229341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*